Pioneering New Methods of Drug Delivery
TissueGen® Inc. provides medical device developers with cutting-edge absorbable polymer technology for implantable drug delivery. Our patented process enables fiber extrusion at room temperature with drugs and therapeutic agents previously impossible to incorporate in implant devices. In more ways than ever, device developers can now take advantage of drug delivery through our ELUTE® biodegradable drug-loaded fiber – an incredible breakthrough that drastically expands the variety of biologics to be delivered via implant.
TissueGen Enhances Intellectual Property Portfolio with New Patent for Self-Expanding Medical Device
Regenerative Neurobiology Experts’ Session at Neuroscience 2014 Demonstrates TissueGen’s Approach to Nerve Repair
TissueGen Expands Core Team and Advances Spinal Cord Injury Repair and Regenerative Medicine Applications in 2014
TissueGen to Showcase ELUTE Fiber for Advanced Drug Delivery, Nerve Regeneration and Tissue Engineering Applications at MD&M West
TissueGen’s ELUTE® biodegradable drug-loaded fiber has been issued a registration certificate by the USPTO